Villaganas, Ruthelia S.

HRN: 21-29-02  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2022
CEFTRIAXONE 1G (VIAL)
04/29/2022
05/06/2022
IV
2G
OD
Pneumonia
Waiting Final Action 
04/29/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/29/2022
05/06/2022
IV
500mg
Q8H
Intra Abdominal Infection
Waiting Final Action 
04/29/2022
RIFAXIMIN 200MG (TAB)
04/29/2022
05/06/2022
PO
200mg
BID
Hepatic Encephalopathy, Intrabdominal Infection
Waiting Final Action 
04/30/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/30/2022
05/07/2022
IVT
4.5
Q6
Pneumonia
Waiting Final Action 
05/10/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/10/2022
05/16/2022
TOPICAL
Ample Amount
Bid
Diaper Rashes
Waiting Final Action 
05/12/2022
LEVOFLOXACIN 500MG (TAB)
05/12/2022
05/18/2022
PO
500mgtab
Q24
Catheter Associated UTI
05/12/2022
LEVOFLOXACIN 500MG (TAB)
05/12/2022
05/18/2022
PO
750mg (1 And 1/2 Tab)
Q24
Catheter Associated UTI
Waiting Final Action 
05/14/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/10/2022
05/16/2022
TOPICAL
Ample Amount
Bid
On Diaper Rash
Waiting Final Action 
05/20/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/20/2022
05/26/2022
TOPICAL
Ample Amount
BID
Diaper Rash
Waiting Final Action 
05/27/2022
CEFTAZIDIME 1GM (VIAL)
05/27/2022
06/02/2022
IV INFUSION
1g
Q8
CAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: